Serotonin syndrome after concomitant treatment with linezolid and citalopram
- PMID: 12715317
- DOI: 10.1086/374558
Serotonin syndrome after concomitant treatment with linezolid and citalopram
Abstract
Linezolid, a new synthetic antimicrobial, is an important weapon against methicillin-resistant Staphylococcus aureus (MRSA). Although there are reports of serotonin syndrome developing after concomitant use of linezolid and the selective serotonin reuptake inhibitor paroxitene, this report concerns a patient receiving citalopram who developed thrombocytopenia, serotonin syndrome, and lactic acidosis and died following long-term linezolid therapy.
Comment in
-
Linezolid and serotonin toxicity.Clin Infect Dis. 2003 Nov 1;37(9):1274-5. doi: 10.1086/378895. Clin Infect Dis. 2003. PMID: 14557977 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
